Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics, Partners Snag $4.3M in EU Funding To Develop Rapid Influenza Dx

NEW YORK (GenomeWeb News) - Enigma Diagnostics said today that the RANGER Consortium, an international group of companies and research institutes, has received a €3 million ($4.3 million) award from the European Commission Framework 7 program to develop a portable, rapid PCR-based test to detect influenza infections and subtypes.
Enigma, based in Porton Down, UK is the coordinator of the RANGER consortium. Other players include Applied Biosystems, Sagentia, Tico Europe, Bruhn Newtech Group, Bioplastics BV, PERA, the UK’s Health Protection Agency, and the Queen Sirikit National Institute of Child Health.
The company said the diagnostic tool will be based on its automated instrumentation, which integrates sample prep with real-time PCR to detect viral RNA in clinical samples.
Enigma said it is also separately developing RT-PCR-based diagnostic tests for chlamydia, gonorrhea, and other sexually transmitted infections.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.